Functional characterization of the MODY1 gene mutations HNF4(R127W), HNF4(V255M), and HNF4(E276Q)

被引:48
|
作者
Navas, MA [1 ]
Munoz-Elias, EJ [1 ]
Kim, J [1 ]
Shih, D [1 ]
Stoffel, M [1 ]
机构
[1] Rockefeller Univ, Lab Metab Dis, New York, NY 10021 USA
关键词
D O I
10.2337/diabetes.48.7.1459
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Genetic studies have shown that mutations in the gene encoding hepatocyte nuclear factor (HNF)-4 alpha, a member of the steroid/thyroid hormone receptor superfamily, give rise to early-onset type 2 diabetes (MODY1). The functional properties of mutant HNF-4 alpha proteins and the molecular mechanisms by which they impair insulin secretion are largely unknown. In the present study, we have investigated transcriptional activation, DNA binding properties, and protein dimerization activity of three HNF-4 alpha missense mutations-HNF4(R127W), HNF4(V255M), and HNF4(E276Q)- that have been associated with type 2 diabetes. We demonstrate that HNF4(E276Q) has lost its ability to bind to HNF-4 consensus binding sites and activate transcription. HNF4(E276Q) had no effect on the functional activity of wild-type HNF-4 alpha in the pancreatic beta-cell line HIT-T15, but it exhibited weak dominant-negative activity in other cell types. Analysis of HNF4(E276Q) protein showed that it exists in two forms: a full length 54-kDa protein and a 40-kDa COOH-terminal protein lacking the NH2-terminal transactivation domain and the DNA binding domain. Immunoprecipitation experiments indicate that this truncated protein can bind to wild-type HNF-4a and may be responsible for the weak dominant-negative effects seen in these cells. In addition, we show that the transcriptional transactivation of HNF4(R127W) and HNF4(V255M) is indistinguishable from that of wild-type HNF-4 alpha, suggesting that they are sequence polymorphisms. Our results demonstrate that HNF4(E276Q) is a loss-of-function mutation and that it identifies glutamic acid 276 in alpha-helix 8 of the ligand-binding domain of HNF-4 alpha protein as a critical residue for DNA binding, transcriptional activation, and protein stability in vivo.
引用
收藏
页码:1459 / 1465
页数:7
相关论文
共 50 条
  • [1] Functional characterization of the MODY1 gene mutations HNF4 α(Q268X)
    Kondo, E
    Sugiyama, T
    Toyoda, N
    DIABETES, 2002, 51 : A260 - A261
  • [2] Functional characterization of the HNF4α isoform (HNF4α8) expressed in pancreatic β-cells
    Ihara, A
    Yamagata, K
    Nammo, T
    Miura, A
    Yuan, M
    Tanaka, T
    Sladek, FM
    Matsuzawa, Y
    Miyagawa, JI
    Shimomura, I
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 329 (03) : 984 - 990
  • [3] Characterization of glucocorticoid receptor and hepatocyte nuclear factor 4α (HNF4α) binding to the hnf4α gene in the liver
    Bailly, Alain
    Briancon, Nadege
    Weiss, Mary C.
    BIOCHIMIE, 2009, 91 (09) : 1095 - 1103
  • [4] Functional characterization of HNF4α in gastric cancer
    Xu, Chang
    Ooi, Wen Fong
    Qamra, Aditi
    Tan, Patrick
    CANCER RESEARCH, 2017, 77
  • [5] Molecular characterization of the HNF4 alpha Q268X (MODY1) mutation.
    Stoffel, M
    Vaisse, C
    Kim, J
    Duncan, SA
    DIABETES, 1997, 46 : 197 - 197
  • [6] Influence of HNF4α and HNF4α-AS1 gene variants on the risk of anti-tuberculosis drugs-induced hepatotoxicity
    Zhang, Jingwei
    Liu, Xingren
    He, Hai
    Zhou, Wei
    Liu, Yao
    Jiang, Peidu
    Feng, Jing
    Zhou, Yi
    Meng, Xianglong
    Deng, Fei
    ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (11) : 11733 - +
  • [7] Control of ACAT2 Liver Expression by HNF4α Lesson From MODY1 Patients
    Pramfalk, C.
    Karlsson, E.
    Groop, L.
    Rudel, L. L.
    Angelin, B.
    Eriksson, M.
    Parini, P.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2009, 29 (08) : 1235 - 1241
  • [8] Roles of HNF1α and HNF4α in Pancreatic β-Cells: Lessons from a Monogenic Form of Diabetes (MODY)
    Yamagata, Kazuya
    PANCREATIC BETA CELL, 2014, 95 : 407 - 423
  • [9] R127W in HNF4α is a loss-of-function mutation causing maturity-onset diabetes of the young (MODY) in a UK Caucasian family
    Bulman, MP
    Ellard, S
    Hattersley, AT
    DIABETOLOGIA, 2000, 43 (09) : 1203 - 1203